Home > M&A deals 2018 > Astellas Pharma, Inc. acquires Potenza Therapeutics, Inc.
Add-on Acquistion · Life Science · December 2018

Astellas Pharma, Inc. acquires Potenza Therapeutics, Inc.

On December 14, 2018, Astellas Pharma, Inc. acquired Potenza Therapeutics, Inc., a life science company in Massachusetts, United States.

Deal at a glance

AnnouncedDecember 14, 2018 TypeAdd-on Acquistion TargetPotenza Therapeutics, Inc. Buyer Astellas Pharma, Inc. SectorLife Science LocationMassachusetts, United States ValueMembers only

Target company

Potenza Therapeutics, Inc.
Massachusetts, United States
Life Sciencesector
-founded
Activestatus
View the company profile →

Buyer

Astellas Pharma, Inc.
Company · 15 deals on record
  • 5th transaction in life science
  • 4th transaction in United States
15deals, all time
6in this sector
2020latest

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Orbus Therapeutics, Inc.Same sector and country · Oct 2026
ArtesRx LLCSame sector and country · Aug 2026
Firefly Bio, Inc.Same sector and country · Jul 2026

Questions about this deal

Who acquired Potenza Therapeutics, Inc.?Astellas Pharma, Inc. acquired Potenza Therapeutics, Inc. on December 14, 2018.

What type of deal was it?It was a add-on acquistion in the life science sector in 2018.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).